Results 121 to 130 of about 294,621 (346)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown +6 more
wiley +1 more source
Palladium-Catalyzed α-Arylation of Esters and Protected Amino Acids
, 2016 Palladium-Catalyzed α-Arylation of Esters and Protected Amino ...
Neil A. Beare (2986554) +2 more
core +2 more sources
Acta Crystallographica Section E: Crystallographic CommunicationsThe structures of four palladium complexes serendipitously isolated after palladium-catalyzed Sonogashira coupling of aryl iodides with terminal alkynes are reported, namely [3,5-bis(trifluoromethyl)phenyl]iodidobis(triphenylphosphane)palladium(II), [Pd ...
Eric Bosch
doaj +1 more source
Palladium-Carbon sigma-bonded Complexes
, 1995 This chapter provides a comprehensive review of the literature (1982-1994) for organopalladium chemistry covering those compounds containing palladium to carbon sigma bonds.
Canty, AJ (15913241)
core
Clinical Validation of Plasma p‐217tau in Neurological Diseases
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
Palladium-Catalyzed Carbonylation of o-Iodophenols with Allenes
, 2016 Palladium-Catalyzed Carbonylation of o-Iodophenols with ...
Howard Alper (1528849) +1 more
core +1 more source
CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao +7 more
wiley +1 more source
Palladium-Catalyzed Carbocyclization/Silastannylation and Distannylation of Bis(allenes)
, 2016 Palladium-Catalyzed Carbocyclization/Silastannylation and Distannylation of Bis ...
Yoongho Lim (2982009) +5 more
core +1 more source
ALDOA Promotes Glycolysis and NLRP3/GSDMD Pyroptosis to Accelerate ALS Progression
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor neuron degeneration. Glycolytic dysregulation is implicated in disease progression, yet the underlying mechanisms remain unclear. This study investigates how Aldolase A (ALDOA) drives ALS progression through glycolysis‐mediated motor neuron pyroptosis.
Kaixin Yan +9 more
wiley +1 more source
Palladium-Catalyzed Enantioselective Oxidations of Alcohols Using Molecular Oxygen
, 2016 Palladium-Catalyzed Enantioselective Oxidations of Alcohols Using Molecular ...
David R. Jensen (2684662) +2 more
core +1 more source